As employers push patients to lower-cost sites of care and regulators nudge providers toward downside risk, value-based care is moving from theory to reality, and it is coming at “lightning speed,” ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...

As costs for medical services continue to rise, many healthcare organizations are reassessing how care is delivered and paid for. The industry is trending away from fee-for-service models, in which ...

Knights of Columbus Asset Advisors (KoCAA) is a faith-driven investment advisory firm managing approximately $29.5 billion in assets. With a mission to provide Catholic-compliant investment solutions, ...

Select the cell(s) where you want the text to appear vertically. Go to the Home tab in the top ribbon. In the Alignment group, click the Orientation drop-down arrow. Choose Vertical Text from the list ...

Please provide your email address to receive an email when new articles are posted on . Using data from the 2023-2024 influenza season, researchers determined cell-based influenza vaccines were ...

In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...

Experts highlight that applying value-based payment models to atrial fibrillation care requires flexible, team-based approaches focused on reducing hospitalizations, repeat procedures, and stroke, ...

Mounting financial pressures, workforce shortages, and rising patient demand are pushing health systems to rethink how they deliver care. The traditional hospital-centered model is giving way to ...

In the pursuit of faster and more reliable recombinant protein production, transient transfection has emerged as a cornerstone of early biopharmaceutical development. Compared to stable transfection, ...

The Centers for Medicare & Medicaid Services (CMS) announced Tuesday that 33 states, as well as the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...